Johnson & Johnson Vision has introduced the Acuvue Oasys with Transitions Light Intelligent Technology, a first-of-its-kind contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the amount of light entering the eye, according to a company news release.
These contact lenses quickly and seamlessly adjust from clear to dark in response to changing light conditions, reducing exposure to bright light indoors and outdoors, including filtering blue light and blocking UV rays.
“This innovation was born out of deep research into consumer lifestyle needs and fits our future-forward approach to caring for human sight,” Xiao-Yu Song, MD, PhD, Global Head of R&D for Johnson & Johnson Vision, said in a company news release. “Acuvue Oasys with Transitions creates and defines an entirely new category of contact lenses that will address unmet needs for patients. After more than a decade of product development and numerous clinical trials involving more than 1,000 patients, we are excited to bring to market a solution to help contact lenses wearers manage the changing light conditions they face every day in their modern, active lives.”
A range of everyday lighting situations, from artificial light to UV rays, can negatively impact eye comfort, vision and health.1,2,3 Some people compensate for these harsh lighting environments by squinting, shielding their eyes, or dimming lights. Acuvue Oasys with Transitions automatically adapt, helping the human eye manage different types of light and varying intensities of brightness throughout the day, according to the news release.
This strategic partnership between Johnson & Johnson Vision and Transitions Optical combines the respective strengths of each company. While Acuvue is a leader in contact lenses, Transitions Optical is the leading provider of photochromic (smart adaptive) lenses. The two companies are working together to research and deliver best-in-class vision care innovations.
Acuvue Oasys with Transitions has received 510(k) clearance from the FDA and is indicated for the attenuation of bright light. The 2-week reusable, spherical contact lens will be marketed by Johnson & Johnson Vision Care and will be commercially available in first half of 2019.
1 American Academy of Ophthalmology. What is Photokeratitis. Available at: https://www.aao.org/eye-health/diseases/photokeratitis-snow-blindness. Accessed 22 Jan 2018.
2 American Optometric Association. UV Protection. Available at: https://www.aoa.org/patients-and-public/caring-for-your-vision/uv-protection. Accessed 22 Jan 2018.
3 Walls HL, Walls KL, Benke G. Eye Disease Resulting From Increased Use of Fluorescent Lighting as a Climate Change Mitigation Strategy. American Journal of Public Health. 2011;101(12):2222-2225.